Delray Beach, Fla. – September 25, 2026 -- The global plant growth regulator market is valued at USD 3.72 billion in 2026 and is projected to reach USD 5.33 billion by 2031, expanding at a compound annual growth rate of 7.4%, according to MarketsandMarkets.

Aachen, Germany – September 21, 2026 -- Grünenthal has agreed to acquire Bayer AG's oncology drug Stivarga® (regorafenib) for up to €375 million, adding an oral cancer treatment sold in more than 90 markets to its portfolio.